ArticlePediatric research2026
Development of late pulmonary hypertension after antenatal inflammation in experimental bronchopulmonary dysplasia.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mesenchyme-derived inflammation during the saccular stage recruits macrophages and alters lung development.JCI insight · 2026Article
- The Inflammatory Nexus of Bronchopulmonary Dysplasia: From Molecular Pathways to Precision Therapeutics.Mediators of inflammation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntenatal inflammation due to chorioamnionitis is strongly associated with the development of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension (BPD-PH) after preterm birth. However, mechanisms linking antenatal stress with temporal changes in the pulmonary circulation leading to BPD-PH during infancy are incompletely understood. We hypothesized that antenatal inflammation impairs lung alveolar and vascular growth that precedes and increases susceptibility for the development of late BPD-PH.
methodsFetal rats received intra-amniotic ETX or saline 2 days before term delivery. We quantified temporal changes in lung structure, mechanics, and pulmonary hemodynamics by echocardiogram at postnatal days 2 (P2), P7, and P14.
resultsAt P2, ETX-exposed pups showed decreased alveolar and vascular growth, without evidence of right ventricular hypertrophy (RVH). Though echocardiography revealed increased interventricular septal flattening, other markers of PH were not different between groups. By P7-P14, echo revealed changes in metrics of PH and RVH. We found sustained reduction of pulmonary vascular and alveolar growth, increased pulmonary artery wall thickness, and worsened lung mechanics in ETX-exposed pups during infancy.
conclusionsAntenatal inflammation impairs lung vascular growth shortly after birth and causes early pulmonary vascular disease, which precedes sequential changes in pulmonary artery remodeling and echocardiogram markers of PH during the postnatal period, even in the absence of postnatal injury. IMPACT: No published preclinical studies have investigated the association between antenatal inflammation (AI) and temporal changes in structure and function of the developing lung circulation that lead to pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD; BPD-PH), despite strong epidemiologic links. We demonstrate that AI causes early abnormalities of pulmonary alveolar and vascular growth, preceding changes in pulmonary mechanics and echocardiographic metrics of PH, which increase over time during infancy without adverse postnatal exposures. These findings support the growing evidence that AI disrupts lung vascular development and that early pulmonary vascular disease increases susceptibility to BPD and BPD-PH in infancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.